Skip to navigation
Skip to main content
Menu
Close
Search drug information, news and resources
Submit
Resource Centers
Open Submenu
Resource Centers
Back
Allergic Disorders
Cardiovascular Disease
Dermatological Disorders
Diagnostic Agents
Endocrine Disorders
Gastrohepatic Disorders
Geriatrics
Hematological Disorders
Immune Disorders
Immunization
Infectious Diseases
Kidney Disease
Metabolic Disorders
Musculoskeletal Disorders
Neurologic Disorders
Nutrition
OB/GYN
Oncology
Ophthalmic Disorders
Oral Health
Otic Disorders
Pain Management
Pediatrics
Poisoning & Drug Dependence
Psychiatric Disorders
Respiratory Disorders
Urological Disorders
Drugs
Open Submenu
Drugs
Back
Drug Search
Browse by Brand
Browse by Generic
Browse by Therapeutic Category
Browse by Manufacturer
More
New Drug Products
Drug Monograph Updates
Drug Treatment Tables
New Drug Products
New Drug Product: Susvimo
New Drug Product: Xywav
New Drug Product: Wegovy
News
Open Submenu
News
Back
Drug News
Alternative Medicine
Safety Alerts and Recalls
Generics News
Drugs in the Pipeline
The Weekly Dose Podcast
Conference Coverage
Guidelines
Medical Technology
Healthcare Policy
Features
Open Submenu
Features
Back
Features
Case Studies
Expert Perspective
How I Treat
Clinician POV
Drug Primer
Latest Features
Court Rules That State’s Medical Malpractice Act Can Apply to Nonpatients
Interview With Dr Tobias Janowitz on Conducting Fully Remote Trials
Interview with Dr Preeti N. Malani, Chief Health Officer at the University of Michigan
My Diagnosis Is...
Clinical Challenge: Facial Growth in Older Man With Sun Damage
Clinical Challenge: Raised Lesion on Back
Clinical Challenge: Expanding Raised Rash
Charts
Tools
Open Submenu
Tools
Back
Expand Your Knowledge
Calculators
ICD-10
Patient Information
Industry Supported Education
Enrich Your Practice
CME Courses
Jobs
Have a Little Fun!
Cartoons
Quizzes
CME/CE
App
Subscribe
Login
Register
Home
»
News
»
Generics News
Generics News
Fylnetra, a Biosimilar to Neulasta, Gets FDA Approval
Publish Date
May 31, 2022
Pirfenidone Tablets Now Available for Idiopathic Pulmonary Fibrosis
Publish Date
May 13, 2022
First Generic Version of Symbicort Gets FDA Approval
Publish Date
March 16, 2022
First Generic Version of Apokyn Drug Cartridges Gets FDA Approval
Publish Date
February 25, 2022
Generic Version of Cystadane Now Available
Publish Date
February 15, 2022
First Generic Version of Restasis Gets FDA Approval
Publish Date
February 3, 2022
Generic Version of Cuvposa Now Available
Publish Date
January 5, 2022
FDA Approves Biosimilar Insulin Product Rezvoglar
Publish Date
December 21, 2021
Generic Version of Carbaglu Now Available
Publish Date
December 21, 2021
Yusimry, a Humira Biosimilar Product, Gets FDA Approval
Publish Date
December 21, 2021
Interchangeable Biosimilars to Lantus Now Available
Publish Date
November 16, 2021
FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths
Publish Date
October 20, 2021
First Generic Version of Chantix Now Available
Publish Date
September 23, 2021
First Generic Version of Clindagel Gets FDA Approval
Publish Date
August 24, 2021
Semglee Approved as First Interchangeable Biosimilar Insulin Product
Publish Date
July 29, 2021
Generic Version of Feraheme Now Available
Publish Date
July 16, 2021
Generic Version of Perforomist Now Available
Publish Date
June 23, 2021
Generic Version of Soolantra Cream Now Available
Publish Date
June 16, 2021
Isotretinoin Capsules, a Generic Version of Absorica, Now Available
Publish Date
April 29, 2021
Generic Version of Foscavir Now Available
Publish Date
March 16, 2021
Load More
MPR ARTICLES
Popular
Emailed
Recent
Loading...
Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Login
Register
Close more info about Fylnetra, a Biosimilar to Neulasta, Gets FDA Approval
Loading...
Close more info about Fylnetra, a Biosimilar to Neulasta, Gets FDA Approval
Loading...